717
Participants
Start Date
February 28, 2013
Primary Completion Date
August 31, 2016
Study Completion Date
November 30, 2016
Lesinurad
Tablets, 200 mg QD
Lesinurad
Tablets, 400 mg QD
Grafton
Witbank
Radiokop
Sowento
Otahuhu
Newtown
Parktown
Rotorua
Heidelberg West
Tauranga
Clayton
Hamilton
Genk
Lommel
Durban
Herston
Newlands
Silverglen
Woodville South
Yvoir
Worcester
Stellenbosch
Paarl
Rondebosch
Beckenham
Kortrijk
New York
Hartsdale
Brooklyn
A Coruña
Clairton
Pittsburgh
McMurray
Scottdale
Indiana
Altoona
Duncansville
Jenkintown
Manassas
Vinnytsia
Cumberland
Midlothian
Richmond
Richmond
Richmond
Virginia Beach
Danville
Morgantown
Winston-Salem
Greensboro
Raleigh
Shelby
Shelby
Charlotte
Wilmington
Calabash
Hickory
Columbia
Spartanburg
Union
Mt. Pleasant
Myrtle Beach
Rock Hill
Conyers
Roswell
Johns Creek
Atlanta
Atlanta
Augusta
Savannah
Port Orange
Jacksonville
Vero Beach
Pembroke Pines
Miami
Miami
Miami
Jupiter
Brandon
Plant City
Tampa
Tampa
Ocala
Brooksville
Pinson
Birmingham
Birmingham
Birmingham
Poltava
Gulf Shores
Spring Hill
Knoxville
Knoxville
Memphis
Lexington
Paducah
Elizabethtown
Colombus
Perrysburg
Willoughby Hills
Cleveland
Middleburg Heights
Franklin
Cincinnati
Cincinnati
Dayton
Dayton
Goch
Southfield
Ann Arbor
Flint
Kalamazoo
Traverse City
Cedar Rapids
Milwaukee
Fargo
Gurnee
Kharkiv
Kharkiv
Hazelwood
Washington
St Louis
Kansas City
Jefferson City
Omaha
Metairie
Metairie
Natchitoches
Little Rock
Little Rock
Little Rock
Oklahoma City
Tulsa
Plano
Irving
Plano
Dallas
Fort Worth
Waco
San Angelo
Houston
Nassau Bay
Houston
Houston
Houston
Kingwood
Sealy
Sugar Land
San Antonio
San Antonio
San Antonio
Austin
Englewood
Denver
Colorado Springs
Colorado Springs
Idaho Falls
Meridian
Meridian
Bountiful
Layton
West Jordan
Salt Lake City
Eichstätt
Mesa
Glendale
Peoria
Albuquerque
Reno
San Diego
Irvine
Anaheim
San Leandro
San Ramon
Roseville
Gold River
Sacramento
Honolulu
Portland
Seattle
Tacoma
Olympia
Spokane
Worcester
Brisbane
Coquitlam
Penticton
Kitchener
London
Toronto
Québec
Dresden
Dresden
Kamenz
Leipzig
Birkinhead
Poznan
Krakow
Katowice
Warminsko-mazurskie
Warsaw
Gmina Końskie
Thabazimbi
Muckleneuk
Mérida
Lausanne
Kyiv
Lead Sponsor
Ardea Biosciences, Inc.
INDUSTRY